Liberty One Investment Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,060
Closed -$1.01M 188
2024
Q1
$1.01M Buy
48,060
+14,218
+42% +$253K 0.11% 85
2023
Q4
$607K Sell
33,842
-2,680
-7% -$47.2K 0.08% 106
2023
Q3
$601K Sell
36,522
-209
-0.6% -$3.79K 0.09% 100
2023
Q2
$734K Buy
36,731
+7,251
+25% +$140K 0.1% 102
2023
Q1
$557K Buy
29,480
+626
+2% +$13.9K 0.08% 107
2022
Q4
$654K Sell
28,854
-564
-2% -$12.8K 0.09% 99
2022
Q3
$778K Buy
29,418
+1,691
+6% +$50.2K 0.13% 92
2022
Q2
$1.08M Sell
27,727
-2,073
-7% -$51.8K 0.18% 89
2022
Q1
$989K Buy
29,800
+277
+0.9% +$7.69K 0.15% 90
2021
Q4
$965K Buy
29,523
+1,016
+4% +$34.6K 0.15% 102
2021
Q3
$1.2M Buy
28,507
+780
+3% +$28.1K 0.2% 81
2021
Q2
$1.08M Buy
27,727
+1,708
+7% +$61.1K 0.18% 89
2021
Q1
$888K Sell
26,019
-767
-3% -$32.7K 0.16% 99
2020
Q4
$1.22M Buy
26,786
+37
+0.1% +$1.29K 0.23% 70
2020
Q3
$736K Buy
26,749
+7,044
+36% +$230K 0.15% 101
2020
Q2
$726K Sell
19,705
-550
-3% -$20.5K 0.16% 80
2020
Q1
$656K Sell
20,255
-740
-4% -$30.8K 0.17% 83
2019
Q4
$860K Buy
+20,995
New +$829K 0.19% 85

Other funds holding RGNX

Liberty One Investment Management's RGNX Position: Q2 2024 in Review

Liberty One Investment Management sold out of Regenxbio (RGNX) in Q2 2024, closing a stake of 48,060 shares — an estimated $1.01M sold.

Liberty One Investment Management first reported a position in RGNX in Q4 2019 and held it in 18 quarters. The position peaked at $1.22M in Q4 2020. 181 funds tracked by Wall St. Rank hold RGNX as of Q2 2024.

  • Liberty One Investment Management reported no remaining Regenxbio position as of Q2 2024 after selling out during the quarter.
  • Liberty One Investment Management sold 48,060 Regenxbio shares in Q2 2024, an estimated $1.01M.
  • Liberty One Investment Management first reported a position in Regenxbio in Q4 2019 and held it in 18 quarters.
  • Liberty One Investment Management's Regenxbio position peaked at $1.22M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Regenxbio as of Q2 2024.

Based on Liberty One Investment Management's 13F filing for Q2 2024, filed 22 Jul 2024.